1. Japan Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Asahi Intecc Co., Ltd.

Asahi Intecc Co., Ltd.

7747.T
Asahi Intecc Co., Ltd.JP flagTokyo Stock Exchange
3,700.00
JPY
-32.00
- -
981.70BMarket Cap
Asahi Intecc Co., Ltd.
7747.T
(Tokyo Stock Exchange)

Recent

price

3,700.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
60.48
63.11
58.97
82.16
110.14
137.74
156.22
168.22
194.05
220.4
217.15
235.6
286.48
331.71
395.95
442.14
195.88
Revenue per Share
5.91
8.52
3.84
12.36
17.06
22.73
27.31
30.43
38.88
43.29
35.25
38.24
40
48.25
58.2
46.92
22.05
Basic EPS, GAAP
9.74
2.94
-5.33
2.86
11.4
10.95
19.47
21.2
13.55
9.44
5.55
-9.84
32.21
23.65
88.96
117.75
- -
Free Cash Flow per Basic Share
0.5
1.56
2.15
1.26
2.92
4.26
5.77
7.47
7.59
9.67
10.79
8.79
11.03
11.99
14.48
20.38
- -
Dividend per Share
39.41
46.37
48.42
61.44
73.11
91.29
114.14
137.9
167.37
205.93
229.91
282.69
323.8
359.79
403.52
430.29
428.28
Book Value per Share
50.48
56.71
54.08
88.45
98.85
124.92
125.17
173.33
204.6
234.64
256.16
332
374.99
426.8
497.02
536.93
528.38
Tangible Book Value per Share
254
254
252
243
256
256
253
254
258
260
260
261
271
272
272
271
272
Basic Weighted Avg Shares
15,340
16,007
14,852
19,969
28,145
35,323
39,511
42,710
50,124
57,217
56,546
61,507
77,748
90,101
107,547
120,025
53,206
Sales/Revenue/Turnover
30.98
35.55
13.72
21.79
21.3
22.58
25.32
25.28
27.48
26.51
22.02
20.81
19.61
20.02
20.59
25.06
16.24
Operating Margin (%)
886
1,015
990
1,178
1,514
1,960
2,287
2,553
2,886
3,460
4,198
4,968
7,473
8,711
9,719
10,145
- -
Depreciation Expense
1,498
2,162
968
3,004
4,360
5,829
6,907
7,725
10,042
11,238
9,179
9,984
10,857
13,106
15,808
12,737
5,988
Net Income, GAAP
33.12
24.41
26.02
36.87
31.15
30.27
25.02
28.4
25.83
24.86
27.48
23.96
30.11
25.18
27.05
31.43
28.51
Effective Tax Rate (%)
9.76
13.5
6.52
15.05
15.49
16.5
17.48
18.09
20.03
19.64
16.23
16.23
13.96
14.55
14.7
10.61
11.25
Profit Margin (%)
7,008
8,584
8,850
14,539
16,926
20,828
20,975
27,433
29,663
33,202
35,007
46,460
58,848
63,945
65,202
75,503
73,193
Working Capital
2,715
3,210
4,679
5,520
6,042
5,737
6,361
3,478
3,310
2,863
4,925
3,450
6,364
3,892
2,589
8,711
1,991
LT Debt
13,254
14,898
14,066
21,925
25,737
32,593
32,264
44,659
53,600
65,451
71,972
92,937
121,127
134,298
151,958
151,350
158,919
Total Equity
16.9
21.34
6.92
9.96
11.94
13.84
17.33
15.92
17.58
16.9
11.65
10.54
8.91
9.4
10.3
12.5
3.91
Return on Invested Capital (%)
10.28
13.24
5.29
13.59
16.64
18.99
19.41
19.02
21.75
20.71
14.51
13.44
11.79
12.21
13.66
10.38
5.17
Return on Capital (%)
16.09
19.87
8.08
22.15
25.94
27.69
26.42
24.19
25.67
23.24
16.2
14.94
13.43
14.12
15.25
11.25
5.44
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'24
Sep'25
Dec'25
ST Debt
5,615
- -
1,581
LT Borrowings
1,087
- -
1,991
LT Finance Leases
1,502
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
272
- -
272
Market Capitalization
612,650
684,768
699,708

Working Capital

FRC

•

in mil. unless spec.
Jun'24
Sep'25
Dec'25
Total Current Assets
94,696
- -
92,994
Cash, Cash Equivalents & STI
38,658
- -
41,563
Accounts Receivable, Net
17,676
- -
16,561
Inventories
29,343
- -
27,013
Total Current Liabilities
29,494
- -
19,801
Payables & Accruals
- -
- -
- -
ST Debt
5,615
- -
1,581
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
17.26%
16.62%
-0.4%
Free Cash Flow
-45.77%
-87.25%
32.28%
Net Income, GAAP
9.33%
7.88%
-19.43%
Sales/Revenue/Turnover
13.23%
16.41%
11.6%
Total Cash Common Dividend
18.93%
16.46%
40.68%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
28,713
25,628
26,392
26,814
107,547
2025
- -
- -
- -
- -
120,025
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
22.37
- -
- -
- -
58.2
2025
- -
- -
- -
- -
46.92
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
14.48
2025
- -
- -
- -
- -
20.38
2026
- -
- -
- -
- -
- -
Similar Companies
NanoString Technologies, Inc. (NSTG)
Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO)
Koninklijke Philips N.V. (PHIA.DE)
EssilorLuxottica S.A. (ESLOF)
Menicon Co., Ltd. (7780.T)
NEXGEL, Inc. (NXGLW)
Business
Asahi Intecc Co., Ltd. develops, manufactures and sells medical devices and precision industrial components. The company operates through Medical and Device segments; the Medical segment offers guidewires including percutaneous transluminal coronary angioplasty (PTCA) guidewires, peripheral guidewires, interventional radiology (IVR) guidewires, neurovascular guidewires and angiography guidewires, together with PTCA guiding catheters, PTCA balloon catheters, penetration catheters, microcatheters and robotic systems/software for surgery and coronary treatments; the Device segment provides ultra-fine stainless steel wire ropes, terminal processed products, element wires, stranded conductors, coils, tubes and other medical/industrial components, as well as OEM/ODM services through subsidiaries including Filmecc Co., Ltd. Asahi Intecc products serve cardiology, peripheral vascular, abdominal vascular, cerebrovascular, gastroenterology and other minimally invasive treatment markets for physicians and healthcare providers worldwide. The company maintains leading global market share in PCI guidewires and operates sales, manufacturing and R&D facilities across Japan, the United States, Europe, China, the Middle East and over 110 countries. Founded in 1976 and headquartered in Seto-shi, Aichi, Japan, Asahi Intecc lists on the Tokyo Stock Exchange Prime Market and Nagoya Stock Exchange Premier Market (7747.T). Recent developments include the November 2024 agreement to acquire Nitta Mold Co., Ltd. as a wholly owned subsidiary to enhance mold design, production and product supply stability; the establishment of manufacturing/development subsidiary Asahi Intecc Medical Device (Nanning) Co., Ltd. in China in November 2024 and its April 2025 incorporation to support Chinese market growth; the April 2025 opening of Asahi Intecc Saudi Regional Headquarters in Riyadh to expand Middle East operations; the May 2025 relocation of Filmecc Co., Ltd.; the August 2025 launch of new Mid-Term Management Plan “Building the Future 2030”; and treasury share activities including acquisitions and cancellations through November 2025.